IonQ vs. Rigetti Computing: Which Is the Better Quantum Computing Stock to Own for the Next 5 Years
These pure plays are making important progress toward their goals.
Mindfully Curated
These pure plays are making important progress toward their goals.
The U.S. stock market has historically delivered exceptional returns following midterm elections.
This ETF offers a smart middle ground for investors anxious about the AI trade but who don’t want to sit on the sidelines.
REDeS trial met efficacy endpoints; ISC revenue surged 44% year over year.
Record $33M revenue and $150M full-year guidance signal AI semiconductor demand acceleration.
Key takeaways Cardano (ADA) trades around $0.188 on Tuesday after breaking below a key support zone, extending its recent decline. ADA funding rates have turned positive, suggesting some traders are still positioning for a potential recovery. ADA faces resistance between $0.215 and $0.218, while a prolonged decline could expose the $0.155 support level. Cardano (ADA) […]
The post Cardano dips below $0.19 as bearish derivatives data signals further losses appeared first on CoinJournal.
The narrative is bullish, but numbers (and pictures) are needed to put it in proper perspective.
The iconic dividend stock can be part of a larger retirement portfolio.
If you think artificial intelligence (AI) stocks are immune to rising interest rates, you’ll be sorely mistaken.
Key takeaways XRP trades below $1.25 on Tuesday as the cryptocurrency struggles to recover. CryptoQuant data points to persistent sell-side dominance in XRP, with large whale orders adding uncertainty to XRP’s outlook. XRP faces immediate resistance at $1.285 and $1.30, while a deeper decline could bring the $1.16 and $1.00 support levels into focus. XRP […]
The post XRP struggles below $1.30 amid growing selling pressure appeared first on CoinJournal.
The chipmaker’s other worst months brought both deeper drops and strong rallies. Which one looks most like today?
CEO Andy Jassy believes Amazon Web Services’ opportunity goes well beyond AI.
Record Q3 results and raised full-year guidance across all metrics.
Revenue grew 12% as newer products like CASGEVY and JOURNAVX ramped up significantly.
Record Q3 results driven by data center AI momentum and industrial market recovery.
The enterprise value of the monster deal was estimated at almost $49 billion.
Production grew 6% as debt fell $500 million, signaling improved momentum.
Redemption revenue surged 23% as publisher network hit all-time high redeemers.
Lymphedema revenue surged 13% as Medicare prior authorization stabilized.
Revenue fell 52% on delivery timing, but debt dropped 55% and guidance rose on margins.